1. Home
  2. List
Reference Patent

Reference - List

  • 124 Hits
  • Search Condition : Filter (MeSH = Carcinoma, Hepatocellular / pathology)
Species Resource Title
Human and Animal Cells Hep G2 Hypoxia accelerates cancer invasion of hepatoma cells by upregulating MMP expression in an HIF-1alpha-independent manner.
Human and Animal Cells Hep G2(RCB0459) Stimulation of apolipoprotein E secretion in human hepatoma Hep G2 cells by a cyclic acylpeptide, N-4909.
Human and Animal Cells HuH-7 Transcription factor KLF9 suppresses the growth of hepatocellular carcinoma cells in vivo and positively regulates p53 expression.
Human and Animal Cells Hep G2(RCB1886) Dual-color fluorescence imaging to monitor CYP3A4 and CYP3A7 expression in human hepatic carcinoma HepG2 and HepaRG cells.
Human and Animal Cells HuH-6(RCB1367) , Hep G2 , HuH-7(RCB1366) SiRNA of frizzled-9 suppresses proliferation and motility of hepatoma cells.
Human and Animal Cells HuH-7(RCB1366) The BAFF/NFκB axis is crucial to interactions between sorafenib-resistant HCC cells and cancer-associated fibroblasts.
Human and Animal Cells HuH-7 , Hep G2(RCB1648) Identification of interleukin-16 production on tumor aggravation in hepatocellular carcinoma by a proteomics approach.
Human and Animal Cells Li-7(RCB1941) Characterization of Cisplatin Effects in Lenvatinib-resistant Hepatocellular Carcinoma Cells.
Human and Animal Cells OS-RC-2(RCB0735) Nanoparticle-Mediated Delivery of 2-Deoxy-D-Glucose Induces Antitumor Immunity and Cytotoxicity in Liver Tumors in Mice.
Human and Animal Cells Li-7(RCB1941) , Hep G2(RCB1886) , HuH-7(RCB1942) Rapid fluorescence imaging of human hepatocellular carcinoma using the β-galactosidase-activatable fluorescence probe SPiDER-βGal.
Human and Animal Cells HuH-7(RCB1366) Inhibition of DTYMK significantly restrains the growth of HCC and increases sensitivity to oxaliplatin.
Human and Animal Cells HuH-7(RCB1366) Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells.
Human and Animal Cells HuH-6(RCB1367) Identification of Chemical Inhibitors of β-Catenin-Driven Liver Tumorigenesis in Zebrafish.
Human and Animal Cells HuH-7 First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway.
Human and Animal Cells Hep G2 Inhibition of histone methyltransferase G9a attenuates liver cancer initiation by sensitizing DNA-damaged hepatocytes to p53-induced apoptosis.
Human and Animal Cells Hep G2(RCB1648) , HuH-7(RCB1366) The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma.
Human and Animal Cells HuH-7 ZNF143-Mediated H3K9 Trimethylation Upregulates CDC6 by Activating MDIG in Hepatocellular Carcinoma.
Human and Animal Cells HuH-7 Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial-Mesenchymal Transition.
Human and Animal Cells Hep G2 (-)-Epigallocatechin-3-gallate Down-regulates Doxorubicin-induced Overexpression of P-glycoprotein Through the Coordinate Inhibition of PI3K/Akt and MEK/ERK Signaling Pathways.
Human and Animal Cells HuH-7 Downregulation of AZGP1 by Ikaros and histone deacetylase promotes tumor progression through the PTEN/Akt and CD44s pathways in hepatocellular carcinoma.